Table 1 Patient characteristics at the diagnosis.
Variable | N = 124 (%) |
|---|---|
Median age (range) | 30 (18–59) |
Female | 75 (60) |
ECOG performance status ≥ 2 | 82 (66) |
ECOG performance status ≥ 3 | 21 (17) |
CS I + II | 77 (62) |
CS III | 10 (8) |
CS IV | 37 (30) |
Extranodal involvement | 42 (34) |
Lungs | 27 (22) |
Chest wall | 7 (5.6) |
Kidney | 3 (2.4) |
Ovary | 3 (2.4) |
Bone marrow | 2 (1.6) |
Central nervous system | 1(0,8) |
Pleural effusion | 42 (34) |
Pericardial effusion | 36 (29) |
Superior vena cava syndrome | 52 (42) |
Extranodal sites > 1 | 4 (3) |
LDH > ULN | 107 (86) |
LDH > 3 × ULN | 33(27) |
IPI score 1 | 34 (27) |
IPI score 2 | 60 (48) |
IPI score 3 | 26 (22) |
IPI score 4 | 4 (3) |
Bulky tumor > 10 mm Max diameter (range) in mm | 103 (83)117 (50–300) |
